2-[4-(Morpholin-4-yl)phenyl]benzothiazole | 95856-76-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: 2-[4-(Morpholin-4-yl)phenyl]benzothiazole
• 英文别名: 2-[4-(Morpholin-4-yl)phenyl]-1,3-benzothiazole；4-[4-(1,3-benzothiazol-2-yl)phenyl]morpholine
• CAS: 95856-76-1
• 化学式: C₁₇H₁₆N₂OS
• 分子量: 296.393
• InChiKey: UNGGLDZQUWFXEF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  21
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  53.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  2-氨基苯硫醇 、 4-苯基吗啉 以100%的产率得到
  参考文献：
  名称：

  DELIGEORGIEV, T. G., DYES AND PIGM., 12,(1990) N, C. 243-248

  摘要：

  DOI：

文献信息

• Novel Green Procedure for the Synthesis of 2-Arylbenzothiazoles Under Microwave Irradiation in Peg 200 Or Peg 400
  作者：Todor G. Deligeorgiev、Stefka Kaloyanova、Aleksey Vasilev、Juan J. Vaquero

  DOI：10.1080/10426501003598648

  日期：2010.10.28

  An improved green procedure for the synthesis of 2-aryl- and 2-hetarylbenzothiazoles by condensation of equivalent amounts of 2,2′-diaminodiphenyldisulfides or 2-aminothiophenols and various aromatic aldehydes in PEG 200/400 under microwave irradiation has been developed. This method allows the synthesis of 2-arylbenzothiazoles in high yields and with high purity regardless of the state of the starting

  已经开发了一种改进的绿色程序，用于通过在微波辐射下在 PEG 200/400 中缩合等量的 2,2'-二氨基二苯基二硫化物或 2-氨基苯硫酚和各种芳香醛来合成 2-芳基和 2-杂芳基苯并噻唑。无论起始化合物的状态（液体或固体）或芳环中取代基的性质如何，该方法都允许以高产率和高纯度合成 2-芳基苯并噻唑。
• Antitumor Benzothiazoles. 3. Synthesis of 2-(4-Aminophenyl)benzothiazoles and Evaluation of Their Activities against Breast Cancer Cell Lines <i>in </i><i>Vitro </i>and <i>in Vivo</i>
  作者：Dong-Fang Shi、Tracey D. Bradshaw、Samantha Wrigley、Carol J. McCall、Peter Lelieveld、Iduna Fichtner、Malcolm F. G. Stevens

  DOI：10.1021/jm9600959

  日期：1996.1.1

  A new series of 2-(4-aminophenyl)benzothiazoles substituted in the phenyl ring and benzothiazole moiety has been synthesized by simple, high-yielding routes. The parent molecule 5a shows potent inhibitory activity in vitro in the nanomolar range against a panel of human breast cancer cell lines, but is inactive (IC50 > 30 mu M) against other cell types: activity against the sensitive breast lines MCF-7 and MDA 468 is characterized by a biphasic dose-response relationship. Structure-activity relationships derived using these cell types has revealed that activity follows the heterocyclic sequence benzothiazole > benzoxazole much greater than benzimidazole and that 2-(4-aminophenyl)benzothiazoles bearing a 3'-methyl- 9a, 3'-bromo- 9c, 3'- iodo- 9f, and 3'-chloro-substituent 9i are especially potent and their activity extends to ovarian, lung, and renal cell lines. Four compounds have been evaluated in vivo against human mammary carcinoma models in nude mice. Compound 9a showed the most potent growth inhibition against the ER(+) (MCF-7 and BO) and ER(-) (MT-1 and MT-3) tumors. Our efforts to identify a pharmacological mechanism of action for these intriguing compounds have not, as yet, been successful.
• DELIGEORGIEV, T. G., DYES AND PIGM., 12,(1990) N, C. 243-248
  作者：DELIGEORGIEV, T. G.

  DOI：——

  日期：——
• BENZAZOLE COMPOUNDS FOR USE IN THERAPY
  申请人：CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED

  公开号：EP0721336A1

  公开（公告）日：1996-07-17
• US5874431A
  申请人：——

  公开号：US5874431A

  公开（公告）日：1999-02-23